Results of animal experiments indicate that T2DM and AD shared similar pathophysiological processes, such as metabolic disorder and damage of insulin pathways (Miklossy and McGeer, 2016); thus, some researchers colloquially termed AD as the type 3 diabetes mellitus. This evidence concerns the gene INS and Alzheimer disease.